AIBeatMaker vs MilkyTracker

AIBeatMaker is a web service that generates instrumental beat drafts from written prompts and briefs. Users can describe a beat’s role, mood, and pace in plain language without opening a DAW. The site presents workflows for rap, trap, lo-fi, EDM, video, podcast, and social media music, plus song and lyric workflows. Paid plans list song extension, Vocal Remover, Stem Splitter, private generations, and unlimited MP3/WAV downloads. The free plan includes daily tries and online streaming, but tracks are public by default, stored for 30 days, and unavailable for download. Starter costs $10 a month billed annually, while Plus costs $14.50 a month billed annually. Annual-billed paid generations made during an active subscription include commercial rights; free and monthly-paid generations do not. Starter allows up to 300 tracks monthly from 150 generations, and Plus up to 1,000 tracks from 500 generations. Dreamspark AI LLC operates the service.

MilkyTracker is a free, open source music application for creating .MOD and .XM module files. It runs on Windows, macOS, Linux, and additional platforms, with source builds also supported. Its tracker workflow aims to recreate Fasttracker II’s module playback and user experience, and .MOD files have ProTracker 2/3 playback modes. The editor supports up to 128 channels and allows simultaneous playback and editing; live mode enables pattern changes during playback. The sample editor includes waveform generators and effects, plus a beta synthesizer for generating looped or single- and multi-cycle waveforms. MilkyTracker imports more than 30 module formats and can load zipped, powerpacked, and UMX modules directly. It exports .MOD, .WAV, and .XM files, and can render songs or patterns to disk or to a sample. MIDI In is supported, but MIDI sequencing, third-party plugins, and cloud collaboration are not. Downloads include Linux AppImage and ZIP builds, Windows ZIP builds, and macOS DMG builds. The project says it will always be free, with optional donations, and its manual says it remains under development and advises use at the user's own risk.